09/04/2024 6:40 AM | Shalev Varda (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 6:06 AM | Daniell Richard (Reporting) Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
08/14/2024 5:24 AM | Hughes Eric A (Reporting) Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
08/12/2024 3:09 PM | Daniell Richard (Reporting) Teva Pharmaceutical Industries (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024 6:32 AM | Jover Placid (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 6:35 AM | Hughes Eric A (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 6:30 AM | Jover Placid (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
|
07/31/2024 3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024 6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 7:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 7:00 AM | MIGNONE ROBERTO (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:03 AM | Teva Pharmaceutical Industries (Issuer) Zaks Tal Zvi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:38 AM | Satchi-Fainaro Ronit (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:41 AM | Crane Rosemary A (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:23 AM | Teva Pharmaceutical Industries (Issuer) Vergis Janet S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:27 AM | Nisen Perry (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:14 AM | BARER SOL J (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:17 AM | Elstein Amir (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:20 AM | LIEBERMAN GERALD M (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:45 AM | MIGNONE ROBERTO (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:47 AM | Satchi-Fainaro Ronit (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:49 AM | Crane Rosemary A (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:51 AM | Teva Pharmaceutical Industries (Issuer) Zaks Tal Zvi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:53 AM | Shalev Varda (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:36 AM | Teva Pharmaceutical Industries (Issuer) Vergis Janet S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:38 AM | LIEBERMAN GERALD M (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:42 AM | Nisen Perry (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:31 AM | BARER SOL J (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:33 AM | Elstein Amir (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:25 AM | Shields Matthew (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:18 AM | Shields Matthew (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/17/2024 6:41 AM | Teva Pharmaceutical Industries (Issuer) Weiss Amir (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 7:30 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2024 7:36 AM | Conway Vikki L (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:12 PM | Teva Pharmaceutical Industries (Filer)
| Form ARS | |
04/16/2024 3:16 PM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A | |
04/09/2024 9:26 AM | Phoenix Holdings Ltd. (Filed by) Teva Pharmaceutical Industries (Subject)
| Form SC 13G/A | |
03/07/2024 3:27 PM | Kalif Eliyahu Sharon (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:27 PM | Francis Richard D (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:57 AM | Bergwerk Dov (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Apple to take the AI industry by storm on September 10 (Ad) Apple is often late to embrace new technologies, yet they almost always go on to crush their competition...
But I believe they're finally set to roll out their first ever AI device by September 10...![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9483&Placement=NativeDisplay&Source=NativeDisplay) Get their details here. |
03/01/2024 5:48 AM | Teva Pharmaceutical Industries (Issuer) Weiss Amir (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:52 AM | Sabag Mark (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:54 AM | Kalif Eliyahu Sharon (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:40 AM | Conway Vikki L (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:43 AM | Daniell Richard (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:45 AM | Drape Eric (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:37 AM | Drape Eric (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 6:42 AM | Francis Richard D (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:37 AM | Kalif Eliyahu Sharon (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/05/2024 6:49 AM | Teva Pharmaceutical Industries (Issuer) Weiss Amir (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 7:03 AM | Phoenix Holdings Ltd. (Filed by) Teva Pharmaceutical Industries (Subject)
| Form SC 13G | |
02/01/2024 6:26 AM | Kalif Eliyahu Sharon (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 6:28 AM | Daniell Richard (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 6:18 AM | Sabag Mark (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 6:22 AM | Drape Eric (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 6:18 AM | Fox Christine (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 6:17 AM | Fox Christine (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/16/2023 6:35 AM | Bergwerk Dov (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:36 AM | Conway Vikki L (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 6:15 AM | Bergwerk Dov (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/05/2023 6:20 AM | Conway Vikki L (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/04/2023 5:05 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 3:05 PM | Shalev Varda (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |